Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.

Inflammation with expression of interleukin 6 (IL-6) in the brain occurs in many neurodegenerative disorders. To better understand the role of IL-6 in such disorders, we examined performance in a learning task in conjunction with molecular and cellular neuropathology in transgenic mice that express IL-6 chronically from astrocytes in the brain. Transgenic mice exhibited dose- and age-related deficits in avoidance learning that closely corresponded with specific progressive neuropathological changes. These results establish a link between the central nervous system expression of IL-6, inflammatory neurodegeneration, and a learning impairment in transgenic mice. They suggest a critical role for a proinflammatory cytokine in the cognitive deficits and associated neuroinflammatory changes that have been documented in neurodegenerative diseases such as Alzheimer disease and AIDS.

[1]  S. Barnum,et al.  Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte‐targeted interleukin‐6 expression , 1996, Glia.

[2]  T. Robbins,et al.  Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Brett,et al.  Evolution of Neuropathologic Abnormalities Associated with Blood-Brain Barrier Breakdown in Transgenic Mice Expressing lnterleukin-6 in Astrocytes , 1995, Journal of neuropathology and experimental neurology.

[4]  F. Gage,et al.  Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion , 1995, Neuroscience.

[5]  S. Ekholm,et al.  Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. , 1995, Stroke.

[6]  E. Masliah,et al.  Differential Vulnerability of Calbindin‐immunoreactive Neurons in HIV Encephalitis , 1995, Journal of neuropathology and experimental neurology.

[7]  L. Mucke,et al.  Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein , 1995, The Journal of experimental medicine.

[8]  U. Staubli,et al.  Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  A. Björklund,et al.  Selective Lesioning of the Basal Forebrain Cholinergic System by Intraventricular 192 IgG–saporin: Behavioural, Biochemical and Stereological Studies in the Rat , 1995, The European journal of neuroscience.

[10]  L. Mucke,et al.  Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. , 1995, Current topics in microbiology and immunology.

[11]  L. Gold,et al.  Behavioral effects of persistent lymphocytic choriomeningitis virus infection in mice. , 1994, Behavioral and neural biology.

[12]  E. Masliah,et al.  Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Henriksen,et al.  Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice , 1994, Brain Research.

[14]  Françoise Condé,et al.  Local circuit neurons immunoreactive for calretinin, calbindin D‐28k or parvalbumin in monkey prefronatal cortex: Distribution and morphology , 1994, The Journal of comparative neurology.

[15]  A. Stalder,et al.  Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. , 1994, Developmental neuroscience.

[16]  H. Arai,et al.  Selective loss of calbindin D28K-immunoreative neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study , 1993, Neuroscience Letters.

[17]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Kalaria.  The Immunopathology of Alzheimer's Disease and Some Related Disorders , 1993, Brain pathology.

[19]  M. Somerville,et al.  Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. , 1993, Brain research. Molecular brain research.

[20]  D. Walker,et al.  Microglia in degenerative neurological disease , 1993, Glia.

[21]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[22]  C. Achim,et al.  Selective Neuronal Vulnerability in HIV Encephalitis , 1992, Journal of neuropathology and experimental neurology.

[23]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[24]  G. Kreutzberg,et al.  Cytotoxicity of microglia , 1992, Journal of Neuroimmunology.

[25]  C. Heizmann,et al.  Changes in Ca2+-binding proteins in human neurodegenerative disorders , 1992, Trends in Neurosciences.

[26]  E. Masliah,et al.  Cortical dendritic pathology in human immunodeficiency virus encephalitis. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[27]  U. Schreiter-Gasser,et al.  Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.

[28]  D. Dickson,et al.  Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[29]  M. Mattson,et al.  Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons , 1991, Neuron.

[30]  S. Akira,et al.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  S. Lipton,et al.  HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.

[32]  H. Hatanaka,et al.  Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats , 1989, Neuroscience Letters.

[33]  K. Frei,et al.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.

[34]  T. Hirano,et al.  Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6 , 1988, Molecular and cellular biology.

[35]  R. Zinkernagel,et al.  Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients , 1988, The Journal of experimental medicine.

[36]  F. Houssiau,et al.  Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. , 1988, Clinical and experimental immunology.

[37]  M. Celio,et al.  Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. , 1986, Science.

[38]  H. Lipp,et al.  Postnatal modification of hippocampal circuitry alters avoidance learning in adult rats. , 1984, Science.